These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2400991)

  • 1. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
    Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
    Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
    Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
    Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.
    Qian F; Bajkowski AS; Steiner DF; Chan SJ; Frankfater A
    Cancer Res; 1989 Sep; 49(17):4870-5. PubMed ID: 2758418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intracellular form of cathepsin B contributes to invasiveness in cancer.
    Szpaderska AM; Frankfater A
    Cancer Res; 2001 Apr; 61(8):3493-500. PubMed ID: 11309313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B-like activity in viable tumor cells isolated from rodent tumors.
    Ryan RE; Crissman JD; Honn KV; Sloane BF
    Cancer Res; 1985 Aug; 45(8):3636-41. PubMed ID: 3893687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential.
    Qian F; Chan SJ; Achkar C; Steiner DF; Frankfater A
    Biochem Biophys Res Commun; 1994 Jul; 202(1):429-36. PubMed ID: 8037744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of multiple cathepsin B mRNAs in murine B16a melanoma.
    Qian F; Frankfater A; Steiner DF; Bajkowski AS; Chan SJ
    Anticancer Res; 1991; 11(4):1445-51. PubMed ID: 1746902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
    Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T
    Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction.
    Keren Z; LeGrue SJ
    Cancer Res; 1988 Mar; 48(6):1416-21. PubMed ID: 3345513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the expression of cathepsin B in B16 melanoma metastatic variants depend on transcription factor Sp1.
    Sitabkhan Y; Frankfater A
    DNA Cell Biol; 2007 Sep; 26(9):673-82. PubMed ID: 17691867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors.
    Qian F; Chan SJ; Gong QM; Bajkowski AS; Steiner DF; Frankfater A
    Biomed Biochim Acta; 1991; 50(4-6):531-40. PubMed ID: 1801719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin B and cystatins: evidence for a role in cancer progression.
    Sloane BF
    Semin Cancer Biol; 1990 Apr; 1(2):137-52. PubMed ID: 2103490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
    Sloane BF; Honn KV; Sadler JG; Turner WA; Kimpson JJ; Taylor JD
    Cancer Res; 1982 Mar; 42(3):980-6. PubMed ID: 7059993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
    Bervar A; Zajc I; Sever N; Katunuma N; Sloane BF; Lah TT
    Biol Chem; 2003 Mar; 384(3):447-55. PubMed ID: 12715895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cathepsin B activity in human lung tumors.
    Krepela E; Kasafírek E; Novák K; Viklický J
    Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
    Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
    Liu B; Marnett LJ; Chaudhary A; Ji C; Blair IA; Johnson CR; Diglio CA; Honn KV
    Lab Invest; 1994 Mar; 70(3):314-23. PubMed ID: 8145526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.